Treat-to-Target Outcomes and Measures of Treatment Success in Three Phase 3 Trials of Tapinarof Cream 1% Once Daily for Mild to Severe Plaque Psoriasis. (2022). SKIN The Journal of Cutaneous Medicine, 6(6), s52. https://doi.org/10.25251/skin.6.supp.52